These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 30615523)

  • 1. Trends In Buprenorphine Prescribing By Physician Specialty.
    Wen H; Borders TF; Cummings JR
    Health Aff (Millwood); 2019 Jan; 38(1):24-28. PubMed ID: 30615523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.
    Chou R; Ballantyne J; Lembke A
    Ann Intern Med; 2019 Sep; 171(6):427-429. PubMed ID: 31450240
    [No Abstract]   [Full Text] [Related]  

  • 3. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Office-Based Buprenorphine Prescribers for Medicare Patients.
    Abraham R; Wilkinson E; Jabbarpour Y; Petterson S; Bazemore A
    J Am Board Fam Med; 2020; 33(1):9-16. PubMed ID: 31907241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine.
    Peterson LE; Morgan ZJ; Eden AR
    J Am Board Fam Med; 2020; 33(1):7-8. PubMed ID: 31907240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.
    Stein BD; Saloner B; Schuler MS; Gurvey J; Sorbero M; Gordon AJ
    JAMA; 2021 Jun; 325(21):2206-2208. PubMed ID: 34061152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steps physicians report taking to reduce diversion of buprenorphine.
    Yang A; Arfken CL; Johanson CE
    Am J Addict; 2013; 22(3):184-7. PubMed ID: 23617857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Buprenorphine Prescribing in Community Health Centers.
    Hartung DM; Voss RW; Bailey SR; Huguet N; Muench J
    JAMA Health Forum; 2024 Apr; 5(4):e240634. PubMed ID: 38669032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
    Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
    Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency.
    Suzuki J; Connery HS; Ellison TV; Renner JA
    Am J Addict; 2014; 23(6):618-22. PubMed ID: 25065457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Waivered Clinicians Prescribing Buprenorphine and Prescription Volume by Patient Limit.
    Luo Q; Erikson CE
    JAMA; 2023 May; 329(20):1792-1794. PubMed ID: 37103912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicians' satisfaction with providing buprenorphine treatment.
    Knudsen HK; Brown R; Jacobson N; Horst J; Kim JS; Collier E; Starr S; Madden LM; Haram E; Toy A; Molfenter T
    Addict Sci Clin Pract; 2019 Aug; 14(1):34. PubMed ID: 31446893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice Predictors of Buprenorphine Prescribing by Family Physicians.
    Peterson LE; Morgan ZJ; Borders TF
    J Am Board Fam Med; 2020; 33(1):118-123. PubMed ID: 31907252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017.
    McBain RK; Dick A; Sorbero M; Stein BD
    Ann Intern Med; 2020 Apr; 172(7):504-506. PubMed ID: 31905379
    [No Abstract]   [Full Text] [Related]  

  • 17. Office-based management of opioid dependence with buprenorphine: clinical practices and barriers.
    Walley AY; Alperen JK; Cheng DM; Botticelli M; Castro-Donlan C; Samet JH; Alford DP
    J Gen Intern Med; 2008 Sep; 23(9):1393-8. PubMed ID: 18592319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine Provision by Early Career Family Physicians.
    Tong ST; Hochheimer CJ; Peterson LE; Krist AH
    Ann Fam Med; 2018 Sep; 16(5):443-446. PubMed ID: 30201642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine Prescribing Not Contingent on Counseling, Other Services.
    Harris E
    JAMA; 2023 Jun; 329(22):1908. PubMed ID: 37223956
    [No Abstract]   [Full Text] [Related]  

  • 20. Adoption of the 275-patient buprenorphine treatment waiver for treating opioid use disorder: A state-level longitudinal analysis.
    Knudsen HK; Lin LA; Lofwall MR
    Subst Abus; 2020; 41(2):259-268. PubMed ID: 31295057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.